M. Michallet

Mutation status and clinical outcome of 89 imatinib mesylate-resistant chronic myelogenous leukemia patients: a retrospective analysis from the French intergroup of CML (Fi(ϕ)-LMC GROUP)

Franck E. Nicolini, Sélim Corm, Q.H. Le et al. · Leukemia · 2006 · 203 citations

Life Sciences, Genetics, Hematology +15

Reduced intensity conditioning allogeneic stem cell transplantation for Hodgkin's lymphoma: identification of prognostic factors predicting outcome

Stephen Robinson, Anna Sureda, Carmen Canals et al. · Haematologica · 2008 · 168 citations · Full text

Medicine, Hematology, Oncology +15

Mucormycosis after allogeneic haematopoietic stem cell transplantation: a French Multicentre Cohort Study (2003-2008)

Aliénor Xhaard, Fanny Lanternier, Raphaël Porcher et al. · Clinical Microbiology and Infection · 2012 · 87 citations · Full text

Medicine, Hematology, Infectious Diseases +12

Long-term outcomes after reduced-intensity conditioning allogeneic stem cell transplantation for low-grade lymphoma: a survey by the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC)

S. Vigouroux, M. Michallet, Raphaël Porcher et al. · Haematologica · 2007 · 82 citations · Full text

Medicine, Oncology, Cell Therapy +13

The BCR-ABLT315I mutation compromises survival in chronic phase chronic myelogenous leukemia patients resistant to tyrosine kinase inhibitors, in a matched pair analysis

Franck E. Nicolini, A. R. Ibrahim, Simona Soverini et al. · Haematologica · 2013 · 80 citations · Full text

Medicine, Oncology, Pharmacology +13